ELTX Elicio Therapeutics, Inc.: institutional ownership and insider trading
65 funds reported holding $29.0M of Elicio Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $10.4M, with 28 new positions and 22 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding ELTX
- Ken Griffin (Citadel Advisors): $583K, 0.0% of the portfolio
Largest institutional holders of ELTX
- Knoll Capital Management, LLC — $4.74M
- VANGUARD GROUP INC — $3.96M
- BlackRock, Inc. (BLK) — $3.00M
- Caption Management, LLC — $2.28M
- SHAH CAPITAL MANAGEMENT — $2.28M
- VANGUARD CAPITAL MANAGEMENT LLC — $2.24M
- Ikarian Capital, LLC — $1.23M
- GEODE CAPITAL MANAGEMENT, LLC — $1.22M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $1.06M
- DIADEMA PARTNERS LP — $829K
5%+ owners
- Moti Investments LLC: 6.1% (Schedule 13G, filed Jul 16, 2026)
- Knoll Capital Management, LLC: 5.3% (Schedule 13G/A, filed Jul 8, 2026)